| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 08/15/2002 | WO2002062207A2 Myeloperoxidase, a risk indicator for cardiovascular disease |
| 08/15/2002 | WO2002062205A2 Methods for diagnosing and treating heart disease |
| 08/15/2002 | WO2002062203A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/15/2002 | WO2002062201A2 Rare event detection system |
| 08/15/2002 | WO2002062198A2 Methods for measuring stress in mammals |
| 08/15/2002 | WO2002062135A2 Scce modified transgenic mammals and their use as models of human disease |
| 08/15/2002 | WO2002062134A1 Human sphingosine-1-phosphate phosphatase |
| 08/15/2002 | WO2002050101A8 Retinoblastoma-binding protein |
| 08/15/2002 | WO2002049502A3 Methods for diagnosing and treating pediatric neoplasms |
| 08/15/2002 | WO2002048698A8 Direct determination of acid distributions in crudes and crude fractions |
| 08/15/2002 | WO2002047266A3 Transient electrical signal based methods and devices for characterizing molecular interaction and/or motion in a sample |
| 08/15/2002 | WO2002046404A9 Schizophrenia-related voltage-gated ion channel gene and protein |
| 08/15/2002 | WO2002044688A3 Analyzing molecular diversity by total pharmacophore diversity |
| 08/15/2002 | WO2002038793A3 Hepatitis c virus constructs characterized by high efficiency replication |
| 08/15/2002 | WO2002038035A3 Methods for inhibiting pain |
| 08/15/2002 | WO2002034109A3 A reagent and kit for determining global coagulability and hemostatic potential |
| 08/15/2002 | WO2002032937A3 Neuromedin u delta |
| 08/15/2002 | WO2002032419A3 Methods for modulating bladder function |
| 08/15/2002 | WO2002028434A3 Use of a ppar delta activator for treating inflammatory conditions |
| 08/15/2002 | WO2002026376A3 High density arrays |
| 08/15/2002 | WO2002023196A3 Fluorescence polarization-based homogeneous assay for deoxynivalenol determination in grains |
| 08/15/2002 | WO2002022160A3 The diagnosis, prevention, amelioration and/or treatment of disturbed immune function induced by disturbed lipid metabolism |
| 08/15/2002 | WO2002018554A3 Isolated human drug-metabolizing proteins, nucleic acid moleculesand uses thereof |
| 08/15/2002 | WO2002017991A3 Respiratory gas sensors in flow path |
| 08/15/2002 | WO2002017901A3 Oxidized forms of retinoic acid as ligands for peroxisome proliferator activated receptor gamma |
| 08/15/2002 | WO2002014870A3 Use of antibodies against specific mhc-peptide complexes |
| 08/15/2002 | WO2002013763A3 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists |
| 08/15/2002 | WO2002008751A3 Mild enrichment of foetal cells from peripheral blood and use thereof |
| 08/15/2002 | WO2002008261A3 Bstp-trans protein and related reagents and methods of use thereof |
| 08/15/2002 | WO2002006828A3 Hemoglobin sensor |
| 08/15/2002 | WO2002002794A3 Integrated microarray devices |
| 08/15/2002 | WO2002002740A3 Methods and compositions for determining gene function |
| 08/15/2002 | WO2002000342A3 Method and apparatus for performing an assay |
| 08/15/2002 | WO2001096875A9 Hcv antigen/antibody combination assay |
| 08/15/2002 | WO2001092303A3 Human ion channels |
| 08/15/2002 | WO2001088177A8 Stain solution, which is devoid of phenol, for bacteria |
| 08/15/2002 | WO2001085995A9 Identification of neural defects associated with the nucleosom al assembly protein 1l2 gene |
| 08/15/2002 | WO2001084107A3 Method for non-invasive spectrophotometric blood oxygenation monitoring |
| 08/15/2002 | WO2001079527A3 Sexual fidelity and sex crime verification |
| 08/15/2002 | WO2001071034A3 Methods and apparatus for parallel magnetic biological analysis and manipulation |
| 08/15/2002 | WO2001066572A9 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof |
| 08/15/2002 | WO2001061039A3 5-hydroxytryptamine transporter gene polymorphisms |
| 08/15/2002 | WO2001059157A3 Process for the enumeration and identification of microorganisms |
| 08/15/2002 | WO2001048481A9 Pyrogenicity test for use with automated immunoassay systems |
| 08/15/2002 | WO2001044813A9 Use of wicking agent to eliminate wash steps for optical diffraction-based biosensors |
| 08/15/2002 | WO2001034302A9 Biochannel assay for hybridization with biomaterial |
| 08/15/2002 | WO2001033190A9 Automated laser capture microdissection |
| 08/15/2002 | WO2001032927A3 Tissue specific genes of diagnostic import |
| 08/15/2002 | WO2001032877A9 CpG RECEPTOR (CpG-R) AND METHODS RELATING THERETO |
| 08/15/2002 | WO2001032802A9 Method and apparatus for predicting male infertility |
| 08/15/2002 | WO2001032320A9 An improved combinatorial testing method and apparatus for coat material formulations and methods |
| 08/15/2002 | WO2001031335A9 Cell proliferation diagnosis and screening for modulators |
| 08/15/2002 | WO2001030768A9 Methods and compositions utilizing quinazolinones |
| 08/15/2002 | WO2001016182A3 POLYPEPTIDES THAT BIND HIV gp120 AND RELATED NUCLEIC ACIDS, ANTIBODIES, COMPOSITIONS, AND METHODS OF USE |
| 08/15/2002 | WO1999064067A9 Vaccine |
| 08/15/2002 | US20020112253 Acetyl-coenzyme a carboxylase 2 as a target in the regulation of fat burning, fat accumulation, energy homeostasis and insulin action |
| 08/15/2002 | US20020111781 Method for protein structure alignment |
| 08/15/2002 | US20020111749 Methods and systems for evaluating defects in metals |
| 08/15/2002 | US20020111747 System and process for analysis |
| 08/15/2002 | US20020111746 Systems and computer software products for gene expression analysis |
| 08/15/2002 | US20020111743 Method for treating objects |
| 08/15/2002 | US20020111741 Network for evaluating data obtained in a biochip measurement device |
| 08/15/2002 | US20020111473 Novel g protein coupled receptor |
| 08/15/2002 | US20020111470 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
| 08/15/2002 | US20020111469 Polypeptide for use in the treatment of tumors, lung defects, inflammation and heart defects |
| 08/15/2002 | US20020111463 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 08/15/2002 | US20020111325 VEGI, an inhibitor of angiogenesis and tumor growth |
| 08/15/2002 | US20020111306 DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
| 08/15/2002 | US20020111303 Protein found in breast, prostate gland cells cancer membrane |
| 08/15/2002 | US20020111293 Modulator of tyrosine kinase receptors |
| 08/15/2002 | US20020111291 Diabetic therapy |
| 08/15/2002 | US20020111290 Calibration of chemokine or receptor expression; medical diagnosis |
| 08/15/2002 | US20020110933 Microarrays for use in the human diagnositic and drug screening |
| 08/15/2002 | US20020110932 Apparatus for use in humans diagnostics and drug development |
| 08/15/2002 | US20020110928 Device for use in the analysis and coding of animal and plants tissues |
| 08/15/2002 | US20020110925 Apparatus and method for testing compositions in contact with a porous medium |
| 08/15/2002 | US20020110924 Device for use in detecting impurities in water |
| 08/15/2002 | US20020110922 Diagnostic apparatus for monitoring blood coagulation |
| 08/15/2002 | US20020110920 Testing system for chemical substances or substance mixtures |
| 08/15/2002 | US20020110919 Screening chemical intermediates for electrophilic properties; provide reaction vessels, fill with reaction mixture, incubate with marker, quantitatively or qualitatively measuring chemi cal marker |
| 08/15/2002 | US20020110916 Diagnostic system for ozone-splitting catalytic converters and method of operation |
| 08/15/2002 | US20020110912 Cancer cells for use as animal model in the treatment of mouth cancer |
| 08/15/2002 | US20020110904 High throughput apparatus for use in quantitative and qualitative analysis of biopolymes in solution |
| 08/15/2002 | US20020110903 Blocking of device for detecting biochemically active molecules |
| 08/15/2002 | US20020110901 Compositions and methods for surface imprinting |
| 08/15/2002 | US20020110900 Low volume chemical and biochemical reaction system |
| 08/15/2002 | US20020110895 Nucleotide sequences coding enzymatic polypeptide for use in treatment of thrombosis and in the immune defects |
| 08/15/2002 | US20020110890 Expression vector for use in the monitoring of cyclic adenosine monophosphate concentration |
| 08/15/2002 | US20020110889 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/15/2002 | US20020110888 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/15/2002 | US20020110883 Novel motor proteins and methods for their use |
| 08/15/2002 | US20020110872 Cytotoxic factors for modulating cell death |
| 08/15/2002 | US20020110862 Novel Siglec-like gene |
| 08/15/2002 | US20020110853 Polypeptide; for use in the treatment of tumors |
| 08/15/2002 | US20020110846 Kit for use in the detection of biopolymers bound to solid support |
| 08/15/2002 | US20020110845 Method for the prediction of starch digestion |
| 08/15/2002 | US20020110844 Test strip for determining dialysate composition |
| 08/15/2002 | US20020110843 Compositions and methods for epitope mapping |
| 08/15/2002 | US20020110842 Photochemical amplified immunoassay |
| 08/15/2002 | US20020110841 Regulation of cell growth by MUC1 |